NorthWest Biotherapeutics Inc (NWBO)

[beachhyena]

JR, please post your credentials as well so we validate your expertise in this field of medicine. Please also let us know how many publications you have in your name.

FYI here are DR Marincola's credentials. Looks like he may just about have a bit more knowledge than you. Right?

President: Professor Francesco Marincola
Dr Matincola is a Chief and Professor of Infectious Disease and Immunogenetics Laboratory Section (IDIS) in DTM. He was appointed as an Associate Director for genomic studies of the Trans-NIH Center for Human Immunology in 2008, and then Director of FOCIS Center for Excellence in Immunology in 2009. Dr. Marincola has made a great contribution in promoting translational medicine worldwide. He lunched the Journal of Translational Medicine as an Editor-in-Chief far before the importance of Translational Medicine was being recognized. He has more than 400 papers published in peer reviewed journals. He is also an Editor-in-Chief for ASHI Quarterly; US Senior Editor of Immunotherapy, Associate Editor for The Journal of Immunotherapy and The Journal of Immunology, Tumori, and Clinical Cancer Research; Section Editor for Expert Opinion in Biological Therapy; Editorial Board for Cancer Immunology & Immunotherapy, The Journal of Experimental and Clinical Cancer Research and Annals of Surgical Oncology. He is a member Scientific Advisory Board for FDA, Pfizer Scientific, and Hybrivax Inc. Dr. Marincola is the President the International Society of Biological Therapy for Cancer (iSBTc).